Federated Hermes, Inc. Intellia Therapeutics, Inc. Transaction History

Federated Hermes, Inc.

$41.2 Billion
Q2 2024

A detailed history of Federated Hermes, Inc. transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Federated Hermes, Inc. holds 2,300,889 shares of NTLA stock, worth $34.5 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

2,300,889

Previous 1,929,700 19.24%

Holding current value

$34.5 Million

Previous $53.1 Million 3.0%

% of portfolio

0.12%

Previous 0.12%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$20.02 - $27.22 $7.43 Million - $10.1 Million	371,189 Added 19.24%	2,300,889 $51.5 Million
Q1 2024 May 14, 2024	SELL	$23.82 - $32.8 $2.06 Million - $2.84 Million	-86,600 Reduced 4.29%	1,929,700 $53.1 Million
Q4 2023 Jan 31, 2024	BUY	$23.16 - $32.34 $5.67 Million - $7.91 Million	244,722 Added 13.81%	2,016,300 $61.5 Million
Q3 2023 Nov 13, 2023	SELL	$31.62 - $45.78 $7.86 Million - $11.4 Million	-248,501 Reduced 12.3%	1,771,578 $56 Million
Q1 2023 May 08, 2023	SELL	$33.3 - $44.82 $2.88 Million - $3.88 Million	-86,566 Reduced 4.11%	2,020,079 $75.3 Million
Q4 2022 Feb 13, 2023	BUY	$33.21 - $62.69 $19.7 Million - $37.1 Million	592,045 Added 39.09%	2,106,645 $73.5 Million
Q3 2022 Nov 14, 2022	BUY	$53.92 - $71.7 $5.19 Million - $6.9 Million	96,300 Added 6.79%	1,514,600 $84.8 Million
Q2 2022 Aug 15, 2022	BUY	$38.49 - $76.21 $30.7 Million - $60.9 Million	798,700 Added 128.91%	1,418,300 $73.4 Million
Q1 2022 May 13, 2022	BUY	$58.27 - $118.99 $4.03 Million - $8.24 Million	69,210 Added 12.57%	619,600 $45 Million
Q4 2021 Feb 14, 2022	SELL	$100.76 - $138.36 $15.8 Million - $21.6 Million	-156,440 Reduced 22.13%	550,390 $65.1 Million
Q3 2021 Nov 15, 2021	SELL	$132.37 - $176.78 $6.11 Million - $8.17 Million	-46,192 Reduced 6.13%	706,830 $94.8 Million
Q2 2021 Aug 16, 2021	BUY	$60.88 - $161.91 $5.6 Million - $14.9 Million	92,037 Added 13.92%	753,022 $122 Million
Q1 2021 May 13, 2021	BUY	$46.59 - $83.68 $7.53 Million - $13.5 Million	161,626 Added 32.37%	660,985 $53 Million
Q4 2020 Feb 12, 2021	BUY	$18.83 - $63.53 $7.17 Million - $24.2 Million	380,640 Added 320.62%	499,359 $27.2 Million
Q3 2020 Nov 12, 2020	BUY	$17.47 - $24.93 $739,470 - $1.06 Million	42,328 Added 55.41%	118,719 $2.36 Million
Q2 2020 Aug 13, 2020	BUY	$11.14 - $22.87 $850,995 - $1.75 Million	76,391 New	76,391 $1.61 Million
Q2 2019 Aug 14, 2019	SELL	$13.88 - $18.41 $9.26 Million - $12.3 Million	-667,000 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$11.39 - $27.13 $5,979 - $14,243	-525 Reduced 0.08%	667,000 $9.1 Million
Q3 2018 Nov 13, 2018	BUY	$25.78 - $32.6 $1.09 Million - $1.38 Million	42,225 Added 6.75%	667,525 $19.1 Million
Q2 2018 Aug 10, 2018	BUY	$20.02 - $30.79 $544,544 - $837,488	27,200 Added 4.55%	625,300 $17.1 Million
Q1 2018 May 09, 2018	BUY	$19.43 - $34.95 $3.85 Million - $6.92 Million	198,100 Added 49.53%	598,100 $12.6 Million
Q4 2017 Feb 14, 2018	BUY	$17.39 - $31.12 $6.96 Million - $12.4 Million	400,000	400,000 $0

Others Institutions Holding NTLA

# of Institutions

320

Shares Held

87.9M

Call Options Held

673K

Put Options Held

865K

View Full List

About Intellia Therapeutics, Inc.

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $1.14B
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

More about NTLA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account

Federated Hermes, Inc. Intellia Therapeutics, Inc. Transaction History